- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
FCS Retains Top Value-based Care Ranking Among OCM Participants
Florida Cancer Specialists & Research Institute (FCS) was ranked at the top among the 126 oncology practices participating in the Oncology Care Model across the country.
Florida Cancer Specialists & Research Institute (FCS) has been enrolled in the Oncology Care Model (OCM) since its inception, and according to Center for Medicare & Medicaid Innovation's (CMMI) most recent OCM reconciliation data, has once again been ranked at the top among the 126 participating oncology practices across the country.
FCS provides care for more than 22,000 OCM beneficiaries annually and has recorded more than $140 million in Medicare savings since 2016. In the last 6-month performance period of 2021, FCS saved Medicare $31.7 million.
“At FCS, our guiding principle is to put the patient first in everything we do; we are laser-focused on providing world-class cancer care while reducing the overall cost of that care for our patients,” said Lucio Gordan, MD, chief medical officer for Therapeutics & Analytics, FCS. “In the long run, quality care doesn’t increase costs, as quality delivered at the right time in the most appropriate venue, often decreases overall costs and prevents adverse events.”
Dr Kathryn Lindley on Pregnancy-Related Cardiovascular Care Gaps and Training Initiatives
December 8th 2023Cardiologists need skills in risk assessment, contraception counseling, and hypertension management for pregnant patients, according to Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center.
Read More
Dr Lucio Gordan Discusses Updated Guidelines Addressing 1q Abnormalities in Multiple Myeloma
October 27th 2023Lucio Gordan, MD, president and managing physician of Florida Cancer Specialists & Research Institute, discusses recently updated clinical guidelines from the National Comprehensive Cancer Network (NCCN) in multiple myeloma, which specifically discuss disease staging and risk stratification and advise clinicians on how to address 1q abnormalities.
Listen
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
